NCT06055010 Improving Pancreatic Cancer Care by the Use of Computational Science and Technology
| NCT ID | NCT06055010 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UMC Utrecht |
| Condition | Pancreatic Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2014-01-01 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2014-01-01 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of the IMPACT project is to set up a data sharing infrastructure between expert centers for pancreatic surgery that enables training, testing and validation of computer science tools to improve quality of care for patients with pancreatic cancer.
Eligibility Criteria
Inclusion Criteria: * ≥18 years of age * Patients who received diagnostic procedures and/or treatment for (suspected) benign and malignant pancreatic lesions as registered in the Dutch Pancreatic Cancer Project (PACAP) audit database and healthy individuals who received an abdominal CT-scan (controls) Exclusion Criteria: \- Subjects who object to the use of their data for the purpose of scientific research
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06055010 clinical trial?
This trial is open to participants of all sexes, studying Pancreatic Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06055010 currently recruiting?
Yes, NCT06055010 is actively recruiting participants. Contact the research team at l.a.daamen-3@umcutrecht.nl for enrollment information.
Where is the NCT06055010 trial being conducted?
This trial is being conducted at Utrecht, Netherlands.
Who is sponsoring the NCT06055010 clinical trial?
NCT06055010 is sponsored by UMC Utrecht. The trial plans to enroll 5,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.